[ Pobierz całość w formacie PDF ]
Article 10.
collapse temperature data obtained by FDM to
12. Cleland JL, Lam X, Kendrick B, Yang J, Yang TH,
freeze-drying cycles, which would be of great value
Overcashier D, Brooks D, Hsu C, Carpenter JF.
in supporting cycle optimization and robustness 2001. A specific molar ratio of stabilizer to protein is
required for storage stability of a lyophilized mono-
testing in freeze-drying.
clonal antibody. J Pharm Sci 90:310 321.
13. Shire SJ, Shahrokh Z, Liu J. 2004. Challenges in
ACKNOWLEDGMENTS
the development of high protein concentration for-
mulations. J Pharm Sci 93:1390 1402.
The authors would like to thank Dr. Michael J. 14. Franks F. 1990. Freeze drying: From empiricism to
predictability. Cryo-Letters 11:93 110.
Pikal for his active participation in discussions for
15. Nail SL, Gatlin LA. 1993. Freeze-drying: Principles
bringing understanding to the results obtained
and practice. In: Avis KE, Lieberman HA, Lechman
during this study.
L, editors. Pharmaceutical dosage forms: Parent-
eral medications, Vol. 2. New York: Marcel Dekker.
REFERENCES
pp 163 233.
16. Franks F. 1998. Freeze-drying of bioproducts: Put-
1. Pikal MJ. 2002. Freeze Drying. In: Swarbrick J, ting principles into practice. Eur J Pharm Bio-
Boylan JC, series editors. Encyclopaedia of Phar- pharm 45:221 229.
maceutical Technology. New York: Marcel Dekker. 17. Hussain AS. 2001. Emerging Science Issues in
pp 1299 1326. Pharmaceutical Manufacturing: Process Analytical
2. Pikal MJ, Costantino HR. 2004. Lyophilization of Technologies, FDA Science Board Meeting.
biopharmaceuticals. In: Borchard RT, Middaught 18. Tang X, Pikal MJ. 2004. Design of freeze-drying
CR, series editors. Biotechnology: Pharmaceutical processes for pharmaceuticals: Practical advice.
aspects, Vol. II. Arlington, VA: AAPS Press. ISBN: Pharm Res 21:191 200.
0-9711767-6-0. 19. Pikal MJ, Shah S. 1990. The collapse temperature
3. Roque ACA, Lowe CR, Taipa MA. 2004. Antibodies in freeze drying: Dependence on measurement
and genetically engineered related molecules: Pro- methodology and rate of water removal from the
duction and purification. Biotechnol Prog 20:639 glassy phase. Int J Pharm 62:165 186.
654. 20. Rambhatla S, Obert JP, Luthra S, Bhugra C, Pikal
4. Pavlou AK, Belsey MJ. 2005. The therapeutic anti- MJ. 2005. Cake shrinkage during freeze drying: A
bodies market to 2008. Eur J Pharm Biopharm combined experimental and theoretical study.
59:389 396. Pharm Dev Technol 1:33 40.
5. Wang W, Singh S, Zeng DL, King K, Nema S. 2007. 21. Passot S, Fonseca F, Barbouche N, Marin M, Alar-
Antibody structure, instability, and formulation. con-Lorca M, Rolland D, Rapaud M. 2007. Effect of
J Pharm Sci 96:1 26. product temperature during primary drying on the
DOI 10.1002/jps JOURNAL OF PHARMACEUTICAL SCIENCES, VOL. 98, NO. 9, SEPTEMBER 2009
3086 MEISTER AND GIESELER
long-term stability of lyophilized proteins. Pharm 34. Dean JA. 1985. Lange s Handbook of Chemistry,
Dev Technol 12:543 553. 13th edition. New York: McGraw-Hill. pp 10 74.
22. Chang BS, Randall CS, Lee YS. 1993. Stabilization 35. Fonseca F, Passot S, Cunin O, Marin M. 2004.
of lyophilized porcine pancreatic elastase. Pharm Collapse temperature of freeze-dried lactobacillus
Res 10:1478 1483. bulgaricus suspensions and protective media. Bio-
23. Allison SD, Randolph TW, Manning MC, Middleton technol Prog 20:229 238.
K, Davis A, Carpenter JF. 1998. Effects of drying 36. American Society for Testing and Materials. 2007.
methods and additives on structure and function of Active standard: ASTM E1356-03, Standard Test
actin: Mechanisms of dehydration-induced damage Method for Assignment of the Glass Transition
and its inhibition. Arch Biochem Biophys 358:171 Temperatures by Differential Scanning Calorim-
181. etry. Book of Standards, Vol. 14.02.
24. Schersch K, Betz O, Garidel P, M�hlau S, Bassarab 37. Gardel ML, Shin JH, MacKintosh FC, Mahadevan
S, Winter G. 2006. Effect of collapse during lyophi- L, Matsudaira P, Weitz DA. 2004. Elastic behavior
lization and during storage an elevated tempera- of cross-linked and bundled actin networks. Science
tures on the stability of pharmaceutical protein 304:1301 1305.
lyophilizates. Proc. CPPR Freeze Drying of Phar- 38. Rambhatla S, Ramot R, Bhugra C, Pikal MJ. 2004.
maceuticals and Biologicals Conference, Garmisch- Heat and mass transfer scale-up issues during
Partenkirchen, Germany. freeze drying: II. Control and characterization of
25. Liu J. 2006. Physical characterization of pharma- the degree of supercooling. AAPS Pharm SciTech
ceutical formulations in frozen and freeze-dried 5:1 9. Article 58.
solid states: Techniques and applications in 39. Pikal MJ, Shah S, Senior D, Lang JE. 1983. Phy-
freeze-drying development. Pharm Dev Technol sical chemistry of freeze-drying: Measurement of
11:3 28. sublimation rates for frozen aqueous solutions by a
26. Hsu CC, Walsh AJ, Nguyen HM, Overcashier DE, microbalance technique. J Pharm Sci 72:635 650.
Koning-Bastiaan H, Bailey RC, Nail SL. 1996. 40. Gieseler H, Kramer T, Pikal MJ. 2007. Use of
Design and application of a low temperature pel- manometric temperature measurement (MTM)
tier-cooling microscope stage. J Pharm Sci 85:70 and SMART freeze dryer technology for develop-
74. ment of an optimized freeze-drying cycle. J Pharm
[ Pobierz całość w formacie PDF ]
